Portfolio company
Hyalex Orthopaedics
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
About
This company develops synthetic cartilage and implant systems to restore damaged joint surfaces for patients with osteoarthritis or cartilage injuries.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Hy2Care
This company develops injectable hydrogel implants that facilitate natural cartilage repair for patients with joint injuries to prevent osteoarthritis.
Atro Medical
This company develops synthetic meniscus prostheses to restore knee function and relieve pain for patients with chronic knee injuries.
Moximed
This company develops implantable shock absorbers for patients with knee osteoarthritis to reduce joint load and delay the need for replacement surgery.
Miach Orthopaedics
This company develops bio-engineered surgical implants to facilitate natural healing of torn anterior cruciate ligaments for patients with knee injuries.
TYBR Health
This company develops a hydrogel system for orthopaedic surgeons to protect tendons and ligaments from internal scarring following surgical procedures.
EpiBone
This company grows personalized bone and cartilage grafts from a patient's own stem cells to treat individuals with skeletal defects.
Peptilogics
This company develops engineered peptide therapeutics to treat and prevent medical device-related infections for patients undergoing joint replacements.
Kuros Biosciences
This company develops bone graft technologies and orthobiologics for surgeons and hospitals to facilitate bone healing and tissue regeneration.
